US President Trump is reportedly targeting Anthropic CEO Amodei as the face of AI "doomerism", Axios reports citing sources

Episodes in which a US administration singles out a named corporate figure or firm as a political antagonist have tended to be the opening move rather than the substance: the usual sequence runs from rhetorical framing to personnel and policy signals, then to concrete instruments such as procurement decisions, antitrust posture, or rulemaking direction. The actors matter here. This White House has prior form in pairing public targeting of executives with subsequent regulatory or contract leverage, while Anthropic's positioning as the safety-forward lab makes it the natural foil in the administration's framing of AI policy as acceleration versus restraint. The distinction worth drawing is between political theatre that dissipates and targeting that precedes an identifiable channel: federal AI procurement choices, the shape of any federal preemption push on state AI rules, and the composition of advisory and standards bodies are the places such pressure has historically surfaced. For the listed equity complex, the transmission is indirect and runs through the AI policy narrative and the peer set of exposed labs and their backers rather than through any single name, since Anthropic is not publicly traded. Worth watching are follow-on statements from other officials and whether the framing is echoed in formal policy documents, which on previous occasions has been the tell that rhetoric is hardening into program.